Progressive, metastatic radioactive iodine-refractory Differentiated Thyroid Carcinoma (DTC)
Drug | Drug Name | Drug Description |
---|---|---|
DB00398 | Sorafenib | A kinase inhibitor used to treat unresectable liver carcinoma, advanced renal carcinoma, and differentiated thyroid carcinoma. |
Drug | Drug Name | Phase | Status | Count |
---|